S. Snapinn, M. Chen, Q. Jiang, and T. Koutsoukos. Pharmaceutical statistics, 5 (4):
273-81(2006)7401<m:linebreak></m:linebreak>LR: 20071115; JID: 101201192; ppublish;<m:linebreak></m:linebreak>Mesures de contrast; RCT.
A. Barratt, P. Wyer, R. Hatala, T. McGinn, A. Dans, S. Keitz, V. Moyer, and G. For. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 171 (4):
353-8(August 2004)3595<m:linebreak></m:linebreak>A companion version of this article directed at teachers of evidence-based medicine http://www.cmaj.ca/cgi/data/171/4/353/DC1/1 - * An interactive version of this article as well as other tools and resources can be found at http://www.ebmtips.net/risk001.asp.;<m:linebreak></m:linebreak>Mesures d'associació.
V. Bertele', L. Angelici, S. Barlera, and S. Garattini. British journal of clinical pharmacology, 65 (6):
955-8(June 2008)4526<m:linebreak></m:linebreak>PUBM: Print-Electronic; JID: 7503323; 2008/04/01 aheadofprint; ppublish;<m:linebreak></m:linebreak>Tests d'equivalència.
J. Delaney, S. Daskalopoulou, and S. Suissa. Pharmacoepidemiology and drug safety, 18 (1):
1-6(January 2009)5076<m:linebreak></m:linebreak>JID: 9208369; 0 (Adrenergic beta-Antagonists); ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Marginal structural models; Exemple.